Rhabdomyosarcoma × Endocrine × 90 days × Clear all
NCT02867592 2026-04-13

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

National Cancer Institute (NCI)

Phase 2 Active not recruiting
109 enrolled 24 charts
NCT03050268 2026-02-09

SJFAMILY

St. Jude Children's Research Hospital

Recruiting
1,500 enrolled